Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Galantamine hydrobromide 4mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Galantamine 8mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Galantamine 16mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Galantamine (as galantamine hydrobromide) 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Galantamine 24mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Galantamine 4mg/mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Galantamine (as galantamine hydrobromide) 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galantamine hydrobromide |
Inferred relationship |
Some |
|
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Galantamine (as galantamine hydrobromide) 8 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Galantamine (as galantamine hydrobromide) 8 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely galantamine (as galantamine hydrobromide) 24 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galantamine hydrobromide |
Inferred relationship |
Some |
1 |